Severity and influencing factors of hyperprolactinemia in hospitalized schizophrenia patients
A cross-sectional study
Datos Bibliográficos
| ID | 15519091 |
|---|---|
| Autores | Yan Yang (0000-0001-8648-9692, Fourth People's Hospital of Sichuan Province), Li Li (0000-0001-9700-9682, Fourth People's Hospital of Sichuan Province), Mi Yang (0000-0003-0690-322X, University of Electronic Science and Technology of China, autor de correspondencia) |
| Año | 2025 |
| Volumen | 16 |
| Páginas | 1658334-1658334 |
| Fecha de publicación | 2025-09-02 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | Frontiers in Psychiatry (JOURNAL) |
| Identificadores de la revista | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Editorial | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2025.1658334 |
| PMID | 40964426 |
| OpenAlex | W4413934888 |
| Idioma | EN |
| Referencias citadas | 1 |
HPRL is highly prevalent in schizophrenia patients, with distinct clinical profiles across severity levels. HPRL severity is associated with specific antipsychotics, anxiolytics, trihexyphenidyl, and metabolic indicators, underscoring the need for risk stratification and individualized management
Cross-sectional study · Psychiatry · Schizophrenia (object-oriented programming · Growth Hormone and Insulin-like Growth Factors · Medicine · Neuroendocrine Tumor Research Advances · Pituitary Gland Disorders and Treatments
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |